Ekberg and colleagues proposed that in type 1 diabetes a deficiency of C peptide, a subunit of the proinsulin molecule, also contributes to nerve damage; their animal studies showed that C-peptide ...

Part of diagnosing type 1.5 diabetes or any other form of diabetes ... will detect low to normal levels in people with type 1.5 diabetes. C-peptide levels will be low or undetectable in cases ...

progressive β-cell destruction has been the hallmark of type 1 diabetes, but residual C-peptide (a surrogate marker for insulin secretion) may be detected over 40 years after initial diagnosis ...

The gold standard treatment for type 1 diabetes mellitus is intensive insulin ... Exogenous insulin requirements, serum levels of HbA 1c and C-peptide, and anti-glutamic acid decarboxylase ...

Cour Pharmaceuticals Development Co. Inc. has obtained IND clearance from the FDA for CNP-103, a nanoparticle in development to address the underlying autoimmunity of type 1 diabetes. A first-in-human ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

SAB-142 shows favorable safety and pharmacodynamic activity in Phase 1 trial, advancing to Phase 2b for type 1 diabetes ... parameters correlative to C-peptide preservation.

(HealthDay News) — For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor ... Patients with type 1 or type 2 diabetes undergoing ...

Medically reviewed by Isabel Casimiro, MD, PhD Type 1.5 diabetes is a controversial diagnosis that combines features of the ...